Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • statsteam
    Member
    • Sep 2009
    • 19

    #1

    TopHat questions

    Hi,

    I have a few general questions.

    I am planning to do the junction mapping using 76bp reads.

    What is the good anchor length to use (I am currently using 5 with a -5 option)?
    Since the reads are long (I used to use 32 bp reads), I am wondering if I can allow more than 3 matches per segment. TopHat currently allows upto 3 mismatches per segment. I initially wanted to set it up with
    --segment-length 76 -- segment-mismatches 4
    but TopHat threw an error saying the number of mismatches is upto 3 per segment. So, I am currently using
    --segment-length 38 --segment-mismatches 2

    Even though my current setting mimics what I wanted to do, it will not be the same as allowing upto 4 mismatches because the 3' end tends to have more sequencing errors.

    Thank you,
    Statsteam
  • colindaven
    Senior Member
    • Oct 2008
    • 417

    #2
    Hi Statsteam,

    I'm new to Tophat but have used Bowtie extensively, which Tophat uses. There is a limit of three mismatches per seed in Bowtie.

    Not sure about your other questions yet.

    Hope that helps

    Colin

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
      by SEQadmin2





      NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification,...
      10-30-2026, 06:46 AM
    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Today, 07:59 AM
    0 responses
    13 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 11-05-2026, 09:25 AM
    0 responses
    32 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 11-03-2026, 11:54 AM
    0 responses
    45 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-28-2026, 09:57 AM
    0 responses
    169 views
    0 reactions
    Last Post SEQadmin2  
    Working...